Pedro A. de Alarcón
- Hematology top 2%
- Platelet Disorders and Treatments 10
- Pharmacy top 2%
- Neurology top 5%
- Neuroblastoma Research and Treatments 8
-
- Lymphoma Diagnosis and Treatment 14
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 10
-
- Acute Lymphoblastic Leukemia research 17
-
- Child Nutrition and Feeding Issues 10
-
- Childhood Cancer Survivors' Quality of Life 9
-
- Infant Nutrition and Health 8
- Co-authors
- Cindy L. SchwartzWendy B. LondonAllen R. ChauvenetLouis S. ConstineDebra L. FriedmanMary Jane PetruzziCameron K. TebbiNancy P. Mendenhall
- Cited by
- HematologyPharmacyNeurology
- Journals
- New England Journal of Medicine (1 paper)Nucleic Acids Research (1 paper)Journal of Clinical Oncology (5 papers)
- Partner nations
- United StatesPeruBelgium
In The Last Decade
Pedro A. de Alarcón
88 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 133
- Hematology 429
- Pharmacy 149
- Neurology 400
- Pathology and Forensic Medicine 464
- Genetics 261
Countries citing papers authored by Pedro A. de Alarcón
This map shows the geographic impact of Pedro A. de Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro A. de Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro A. de Alarcón more than expected).
Fields of papers citing papers by Pedro A. de Alarcón
This network shows the impact of papers produced by Pedro A. de Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro A. de Alarcón. The network helps show where Pedro A. de Alarcón may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pedro A. de Alarcón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2015 | 44 | |
| 6 | 2010 | 21 | |
| 7 | 2005 | 34 | |
| 8 | 2005 | 6 | |
| 9 | 2003 | 51 | |
| 10 | Effect of oral nutritional supplementation with or without synbiotics on sickness and catch-up growth in preschool children | 2002 | 8 |
| 11 | 2002 | 28 | |
| 12 | 2002 | 12 | |
| 13 | 2002 | 16 | |
| 14 | 2001 | 46 | |
| 15 | 2001 | 1 | |
| 16 | 1991 | 3 | |
| 17 | 1990 | 10 | |
| 18 | 1990 | 6 | |
| 19 | 1988 | 6 | |
| 20 | 1983 | 7 |
About Pedro A. de Alarcón
Pedro A. de Alarcón is a scholar working on Hematology, Genetics and Pharmacy, having authored 91 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (17 papers), Lymphoma Diagnosis and Treatment (14 papers), Child Nutrition and Feeding Issues (10 papers), Platelet Disorders and Treatments (10 papers), Hemoglobinopathies and Related Disorders (10 papers), Childhood Cancer Survivors' Quality of Life (9 papers), Infant Nutrition and Health (8 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Hematology (429 citations), Pharmacy (149 citations) and Neurology (400 citations). Pedro A. de Alarcón has collaborated with scholars based in United States, Peru and Belgium. Frequent co-authors include Cindy L. Schwartz, Wendy B. London, Allen R. Chauvenet, Louis S. Constine, Debra L. Friedman, Mary Jane Petruzzi, Cameron K. Tebbi, Nancy P. Mendenhall, Doojduen Villaluna and Richard Sposto. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.